Travel Vaccines Market
Report ID: SQMIG35I2375
Travel Vaccines Market Trends
Skyquest Technology's expert advisors have carried out comprehensive research on the travel vaccines market to identify the major global and regional market trends and growth opportunities for leading players and new entrants in this market. The analysis is based on in-depth primary and secondary research to understand the major market drivers and restraints shaping the future development and growth of the industry.
Travel Vaccines Market Dynamics
Travel Vaccines Market Drivers
Rising International Travel and Regulatory Health Requirements
- The surge in global tourism is a critical driver for the travel vaccine industry. According to the UNWTO, international tourist arrivals reached 1.29 billion in 2023, a sharp rebound from pandemic lows. Countries like Saudi Arabia and Australia now mandate proof of vaccination for diseases like yellow fever for travelers from endemic regions. Pharmaceutical companies like Sanofi reported in their 2023 annual report a 10.4% growth in travel vaccine revenues, highlighting how regulatory health checks are boosting demand.
Emerging Infectious Disease Outbreaks and Public Health Initiatives
- The growing frequency of outbreaks — such as the 2022 Marburg virus cases in Ghana — underscores the need for preventive vaccination among travelers. The CDC and WHO issued urgent travel health advisories, amplifying public awareness. In response, companies like GSK expanded production of vaccines like Rabipur (rabies vaccine), as noted in their 2023 Investor Presentation. Government-backed campaigns, like the U.S. CDC’s Global Health Protection Initiative, have also significantly fueled industry expansion.
Travel Vaccines Market Restraints
High Cost of Travel Vaccines and Limited Insurance Coverage
- Travel vaccines often come with high out-of-pocket expenses, discouraging uptake. The CDC reported in 2023 that common travel vaccines like yellow fever and typhoid can cost between $150–$350 per dose, with most insurance plans excluding them. Companies like Emergent BioSolutions acknowledged in their 2023 Annual Report that vaccine affordability remains a barrier to wider market penetration, particularly among budget-conscious travelers in emerging economies.
Vaccine Supply Shortages and Manufacturing Challenges
- Global vaccine shortages, particularly for yellow fever and rabies, have constrained market growth. Sanofi publicly noted in its Investor Update that production disruptions at its Marcy-l'Étoile facility led to limited supply of Stamaril (yellow fever vaccine) across several regions. WHO's 2023 health bulletins also flagged multiple supply bottlenecks, exacerbated by complex cold-chain requirements, highlighting the fragile nature of vaccine availability in the travel sector.
Travel Vaccines Market Report Snapshots
REQUEST FOR SAMPLE
Want to customize this report?
REQUEST FREE CUSTOMIZATION
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
